iBio, Inc. (IBIO)
2.79
+0.57
(+25.68%)
USD |
NASDAQ |
Dec 10, 12:57
iBio Market Cap: 62.74M for Dec. 10, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Minerva Neurosciences, Inc. | 26.44M |
| Bionano Genomics, Inc. | 17.10M |
| NovaBay Pharmaceuticals, Inc. | 279.74M |
| Palatin Technologies, Inc. | 25.84M |
| Theriva Biologics, Inc. | 7.591M |
Market Cap Related Metrics
| PS Ratio | 123.32 |
| Price to Book Value | 1.120 |
| Price | 2.79 |
| Earnings Yield | -49.94% |